If you use sunscreen lotion instead of a spray, more of the active chemicals get into your bloodstream—so lotions might leave more oxybenzone and avobenzone in your body than sprays do.
Evidence Quality Assessment
Claim Status
appropriately stated
Study Design Support
Design supports claim
Appropriate Language Strength
probability
Can suggest probability/likelihood
Assessment Explanation
The claim is based on measurable pharmacokinetic data from human studies comparing absorption across formulations. While multiple studies (e.g., FDA 2019, JAMA) have shown higher plasma levels with lotions, the magnitude of difference can vary by application amount, skin area, and individual metabolism. The use of 'generally' reflects natural variability, making 'probability' the correct verb strength. A definitive claim would overstate consistency across all individuals and conditions.
More Accurate Statement
“Sunscreen lotions tend to produce higher plasma concentrations of oxybenzone and avobenzone than spray formulations, based on current human pharmacokinetic studies.”
Context Details
Domain
medicine
Population
human
Subject
Different sunscreen formulations (lotion, aerosol spray, nonaerosol spray, pump spray)
Action
result in
Target
varying plasma concentrations of active ingredients (oxybenzone and avobenzone), with lotion generally producing higher levels than sprays
Intervention Details
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.
Evidence from Studies
Supporting (1)
Effect of Sunscreen Application on Plasma Concentration of Sunscreen Active Ingredients: A Randomized Clinical Trial.